Gene therapy slows Huntington’s by 75 percent

Study highlights functional preservation in patients and signals the potential for pre-symptomatic intervention. For decades Huntington’s disease has stood as both a genetic certainty and a model of accelerated cellular aging; new clinical trial data now show that decline can be delayed. Results released by uniQure demonstrate that AMT-130, an experimental gene therapy delivered in […] The post Gene therapy slows Huntington’s by 75 percent appeared first on Longevity.Technology.